J.D. Power and Associates Reports that Relationship Marketing ...

Studies from Genentech, Inc. Yield New Information about Molecular Pharmaceutics Molecular PharmaceuticsNewsRx.com By a News Reporter-Staff News Editor at Drug Week -- Current study results on Molecular Pharmaceutics have been published. According ...

Campuses at the University of Texas, such as the MD Anderson Cancer Center in Houston, can boast of star-studded faculties to rival the innovative scientific leadership at UC San Francisco, UC Berkeley and Stanford University. In 2009, the ...

The 7th Annual Survivor Beach Event Will Feature New Stand-Up Paddleboard (SUP) Competition Press Release from Supconnect Media - spreading the news on behalf of: UC San Diego News REGISTER FOR THE EVENT HERE: Survivor Beach SUP Event LA ...

_ This story appears in the May 27 issue of Forbes. Flipboard recently unveiled a new version of its successful tablet magazine app as the entire staff stood around their Palo Alto, Calif. office gawking at the traffic numbers. As the needle starts ...

Great work culture and collegial leadership results in a prestigious award for the second year in a row. Arena Solutions, pioneer of cloud PLM applications, announced that it has been named one of the 2013 Best Places to Work in the Bay Area by the ...

* Shares jump five-fold in two years, market value $26 bln * Bullish forecasts for eye drug, other treatments in pipeline * Risks include high valuation, competitive threats TARRYTOWN, N.Y., May 7 (Reuters) - Just two years ago, Regeneron ...

Pharmaceutical Automation Roundtable (PAR) 2012 Part 6 This is the sixth article of a series about the annual Pharmaceutical Automation Roundtable (PAR). I attended the Roundtable in November 2012, hosted by AbbVie, which at the time was part of ...

Disclosures: : Novartis Oncology, Celgene Corporation, Medarex Pharmaceuticals (RF); : Agennix, Boehringer Ingelheim, Genentech, Lilly, Teva (C/A). Objectives. Disparity exists between patients with lung cancer enrolled in clinical trials and ...

Phase 2 HSPPC-96 Data in Newly Diagnosed GBM Patients The single-arm, Phase 2 trial of HSPPC-96 in patients with newly diagnosed GBM included a total of 46 patients treated at eight centers across the United States. Patients were treated with ...